Literature DB >> 9704010

Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures.

J Zhang1, J O Price, D G Graham, T J Montine.   

Abstract

Dopamine (DA) and related catechols may contribute to selective degeneration of dopaminergic neurons in the substantia nigra in Parkinson's disease. To investigate whether DA induces apoptosis of dopaminergic neurons, we characterized the effects of various concentrations of exogenous DA on a substantia nigra/neuroblastoma hybrid cell line (MES 23.5 or MES). The hybrid MES cells were maintained in the presence of 50 microM glutamate in logarithmic growth on poly-D-lysine-precoated T-75 flasks and plated either onto petri dishes with glass coverslips for morphological studies or onto 6-well plates for quantification of apoptosis by flow cytometry. The results showed that DA exposure (0.5-20 microM) induced time- and dose-dependent apoptotic cell death of MES cells. To further analyze the mechanism responsible for DA-mediated apoptosis, we repeated the experiments at 20 microM DA in the presence or absence of 40 microM nomifensine, a DA re-uptake inhibitor, and 25 microM 2-amino-5-phosphonopentanoic acid (AP5), an N-methyl-D-aspartate (NMDA) receptor antagonist. The data indicate that both compounds significantly prevented DA-induced apoptosis of MES cells and that combination of AP5 and nomifensine provided greater protection against DA toxicity than AP5 alone. These results suggest for the first time that DA-induced apoptosis in dopaminergic neurons is partially attributable to increased vulnerability of these cells to non-toxic levels of excitatory amino acids, i.e., secondary excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704010     DOI: 10.1006/bbrc.1998.9044

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.

Authors:  H Elkon; E Melamed; D Offen
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

Review 4.  Possible mechanisms of neurodegeneration in schizophrenia.

Authors:  Iván Pérez-Neri; Jesús Ramírez-Bermúdez; Sergio Montes; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-09-28       Impact factor: 3.996

5.  Hypoxia-Associated Changes in Striatal Tonic Dopamine Release: Real-Time in vivo Measurements With a Novel Voltammetry Technique.

Authors:  Abhijeet S Barath; Aaron E Rusheen; Juan M Rojas Cabrera; J Blair Price; Robert L Owen; Hojin Shin; Dong Pyo Jang; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Front Neurosci       Date:  2020-08-18       Impact factor: 4.677

6.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

7.  A role for a novel protein, nucleolin, in Parkinson's disease.

Authors:  W Michael Caudle; Efstathia Kitsou; Jane Li; Joshua Bradner; Jing Zhang
Journal:  Neurosci Lett       Date:  2009-05-04       Impact factor: 3.046

8.  The biochemical basis of Parkinson's disease: the role of catecholamine o-quinones: a review-discussion.

Authors:  John Smythies; Angela De Iuliis; Lucia Zanatta; Lauro Galzigna
Journal:  Neurotox Res       Date:  2002-02       Impact factor: 3.911

9.  Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells.

Authors:  Jinghua Jin; Jeanne Davis; David Zhu; Daniel T Kashima; Marc Leroueil; Catherine Pan; Kathleen S Montine; Jing Zhang
Journal:  BMC Neurosci       Date:  2007-08-16       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.